| # | Drug | Count |
|---|---|---|
| 0 | METHYLPREDNISOLONE | 243 |
| 1 | PREDNISOLONE | 235 |
| 2 | PREDNISOLONE ORAL | 235 |
| 3 | PREDNISOLONE ORAL SOLUTION | 235 |
| 4 | TACROLIMUS | 178 |
| 5 | CYCLOPHOSPHAMIDE | 162 |
| 6 | CYCLOPHOSPHAMIDE FOR INJECTION | 162 |
| 7 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 162 |
| 8 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 162 |
| 9 | TACROLIMUS OINTMENT 0.1% | 162 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BARICITINIB | 27 | 0.0088 |
| 1 | VANCOMYCIN HYDROCHLORIDE | 47 | 0.0056 |
| 2 | REMDESIVIR | 71 | 0.0053 |
| 3 | BLEOMYCIN SULFATE | 51 | 0.0049 |
| 4 | ISOFLURANE | 9 | 0.0046 |
| 5 | CISATRACURIUM BESYLATE | 9 | 0.0040 |
| 6 | LEVONORGESTREL AND ETHINYL ESTRADIOL | 10 | 0.0036 |
| 7 | NITROUS OXIDE | 8 | 0.0036 |
| 8 | TREOSULFAN | 9 | 0.0033 |
| 9 | CLINDAMYCIN PHOSPHATE | 17 | 0.0031 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 645 |
| 1 | Alkylating Drug [EPC] | 191 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 110 |
| 3 | Platinum-based Drug [EPC] | 104 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 100 |
| 5 | Calcineurin Inhibitor Immunosuppressant [EPC] | 97 |
| 6 | Kinase Inhibitor [EPC] | 74 |
| 7 | Azole Antifungal [EPC] | 73 |
| 8 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 71 |
| 9 | CD20-directed Cytolytic Antibody [EPC] | 70 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 71 | 0.0053 |
| 1 | Surfactant [EPC] | 4 | 0.0034 |
| 2 | CD38-directed Cytolytic Antibody [EPC] | 20 | 0.0034 |
| 3 | Prostacycline [EPC] | 2 | 0.0021 |
| 4 | Human Blood Coagulation Factor [EPC] | 1 | 0.0012 |
| 5 | Echinocandin Antifungal [EPC] | 9 | 0.0011 |
| 6 | Penem Antibacterial [EPC] | 37 | 0.0011 |
| 7 | Antimetabolite Immunosuppressant [EPC] | 22 | 0.0010 |
| 8 | Sulfone [EPC] | 11 | 0.0010 |
| 9 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 22 | 0.0010 |